Journal of Parkinson's Disease

02/01/2026

Webinar: A deeper look at young onset Parkinson’s, 28 January 2026, 5-6pm GMT, 12-1pm ET.

In this webinar, Edinburgh University’s Professor Tilo Kunath will be joined by an expert panel to discuss what YOPD is and how it differs from idiopathic (typical) Parkinson’s, as well as the potential genetic links. Furthermore, the panel will explore research opportunities for people with YOPD.

You can register to attend this webinar live at: https://cureparkinsons.org.uk/2025/12/webinar-a-deeper-look-at-young-onset-parkinsons/

Held in partnership with the University of Edinburgh and the Journal of Parkinson’s Disease, with Edinburgh University’s Professor Tilo Kunath as chair,

19/12/2025

JPD will attend the World Parkinson's Congress 2026 in Phoenix Arizona, with a booth presence in the exhibit hall. We are happy and proud to announce that the the congress abstracts will again be published in JPD. We look forward to connecting with many of you there! Note that early registration for the meeting runs until January 15: https://wpc2026.org/

What: 7th World Parkinson CongressWho is invited: All stakeholders in the Parkinson’s communityWhen: Sun., May 24 – Wed., May 27, 2026Where: Phoenix, Arizona, USAAddress: Phoenix Convention Center

08/12/2025

DECEMBER ISSUE: https://journals.sagepub.com/toc/pkna/15/8

This issue includes Review article "Beyond the brain: The colorectal impact of Parkinson's disease" by Khan et al.

And a new entry of the special section Advice to People with Parkinson's in my Clinic on "How to manage running-induced dystonia", by Callisaya et al.

Table of contents for Journal of Parkinson’s Disease, 15, 8

08/12/2025

New groundbreaking article: A PLAN to address the Parkinson pandemic, by Dorsey at al.

"Parkinson's is one of the world's fastest growing brain diseases, and most of it is preventable. Adjusted for age, the prevalence of Parkinson's has increased 60% over the last thirty years. Chemicals in our food, water, and air are helping fuel its rise. Many of these are inhaled (come in through the nose) or ingested (enter through the gut). To address the Parkinson pandemic, we propose a “PLAN” to (1) Prevent the disease; (2) Learn why it starts; (3) Amplify the voices of those affected; and (4) Navigate the frontier of new treatments. By doing so, we can reach bold goals by 2035..."

Read more: https://journals.sagepub.com/doi/full/10.1177/1877718X251378115

The Parkinson pandemic continues to spread. Almost 12 million individuals now have the disease, nearly double the estimate from just six years ago. Its human-ma...

06/10/2025

New to Read: A Review article on "Care partner needs in Parkinson's disease: A systematic review of qualitative and quantitative data" by Hulshoff et al. This study looks into understanding the needs of care partners for persons with Parkinson's disease (PD), and how to ease their burden and help with their important role.

Background Care for persons with Parkinson's disease (PD) is to a great extent carried out by care partners. It is important to understand their needs to e...

03/10/2025

“We know that there are a variety of different biological drivers that potentially influence Parkinson’s, and so the aim of this funding call is to increase the odds in our favour for identifying a disease-modifying therapy for Parkinson’s by targeting different aspects of the condition. We hope that this will pave the way for future success and help us to find a cure more quickly.” – Dr Simon Stott, Director of Research

Exciting announcement! We are now accepting expressions of interest for our new £2 million funding call to encourage the testing of rationally designed combinations of two or more drugs with disease-modifying potential for Parkinson’s.

Researchers interested in applying will need to submit an expression of interest by 24 November to be considered. These will be reviewed internally, and those within our funding remit will be invited to submit a full application.

Find out more: https://buff.ly/PowBxQZ

03/10/2025

New Quarterly Webinar: Deep Brain Stimulation (DBS) for Parkinson's: The next steps.

Deep Brain Stimulation (DBS) is a surgical treatment for Parkinson’s that involves implanting electrodes in the brain. These electrodes produce electrical impulses that stimulate brain activity, which can help relieve Parkinson’s motor symptoms.

Presented by Edinburgh University, Journal of Parkinson’s Disease and Cure Parkinson’s, this edition focuses on DBS, with a special emphasis on an emerging form of this therapy: adaptive DBS. Edinburgh University’s Professor Tilo Kunath is joined by an expert panel to discuss what DBS is, how the therapy works and interacts with the brain, and whether DBS, especially adaptive DBS, could have a disease-modifying effect.

https://youtu.be/deBhcW-CbQQ

Deep Brain Stimulation (DBS) is a surgical treatment for Parkinson’s that involves implanting electrodes in the brain. These electrodes produce electrical im...

28/08/2025

Join the upcoming webinar: Deep Brain Stimulation (DBS) for Parkinson's: The next steps

Date: Wed, 24 Sep 2025 18:00 - 19:00 CEST
Time: 18:00 - 19:00 CEST

In collaboration with the University of Edinburgh and the Journal of Parkinson’s Disease, the next in this quarterly webinar series on 24th September at 5.00 pm BST will be on DBS, with a special focus on an emerging form of this therapy: adaptive DBS.

Key topics:
- what is DBS
- how does the therapy work and interact with the brain
- could DBS, especially adaptive DBS, have a disease-modifying effect

Register now: https://www.eventbrite.co.uk/e/deep-brain-stimulation-dbs-for-parkinsons-the-next-steps-registration-1566230540709?aff=JOPD

Our latest online webinar held in collaboration with the Journal of Parkinson's Disease and the University of Edinburgh.

09/04/2025

The newest issue, Volume 15:2, is available now at https://journals.sagepub.com/toc/pkna/15/2. It includes the Review article "Aging, cellular senescence and Parkinson's disease" by Y Ma, ML Erb and DJ Moore. It discusses the hallmarks of
cellular senescence in the context of neuroscience and reviews studies that directly examine cellular senescence in PD.

Table of contents for Journal of Parkinson’s Disease, 15, 2

02/04/2025

has kicked off in Vienna, bringing attendees here live and online the newest updates in Alzheimer's and Parkinson's research as well as networking opportunities. Looking to publish your study and have questions? You can find the Journal of Alzheimer's Disease (and open access sister JAD Reports) and the Journal of Parkinson's Disease in the exhibit hall, next to the poster area.

21/03/2025

JPD now has a LinkedIn page to post news, alerts for the newest content, and updates on our initiatives and collaborations. Don't miss out and follow us at

The Journal of Parkinson’s Disease is dedicated to providing an open forum for original research in basic science, translational research and clinical medicine that will expedite our fundamental understanding and improve treatment of Parkinson’s disease. The journal is international and multidis...

05/03/2025

📢 Tomorrow! Free Webinar 🧠♀️

Women are underrepresented in Parkinson’s research. Join us March 6, 18:00 - 19:00 CET to explore why s*x & gender differences matter.

🔗 Sign up: https://www.eventbrite.co.uk/e/webinar-addressing-the-s*x-and-gender-gaps-in-parkinsons-research-registration-1237068568389?aff=CPWebsite